Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ConvaTec Makes Competing Bid For Wound Care Company Kinetic Concepts

This article was originally published in The Gray Sheet

Executive Summary

Kinetic Concepts Inc. would have to pay a break-up fee of $51.8 million to its current private equity merger partners if it accepts a superior, rival proposal from ostomy and wound care device maker ConvaTec.

You may also be interested in...



Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2011

Medical device companies raised a total of $906 million in Q3, while in vitro diagnostic/research developers took in $72 million. The top M&As in each segment were private buyouts of public companies: Kinetic Concepts for $6.3 billion and Immucor for $1.9 billion.

As DME Bidding Program Rolls Ahead, Auction Researchers Call It “Fatally Flawed”

CMS is moving forward as planned with a 10-fold expansion in the number of metropolitan areas where Medicare will pay for popular durable medical equipment at reduced, competitively bid rates.

Kinetic Concepts To Go Private Via $6.3 Billion Buyout

Kinetic Concepts’ acceptance of a $6.3 billion private equity buyout deal with a consortium of investors, announced July 13, could mark the opening salvo of a bidding war for the wound care device maker.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT030473

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel